You must have the latest - Flash plugin - to view this slideshow. 63-year history of research and clinical excellence
Discover Care Believe - boy on pier 

"Discover. Care. Believe." highlights Dana-Farber breakthroughs

Dana-Farber Cancer Institute has launched DiscoverCareBelieve.org, a new platform to illustrate what sets Dana-Farber apart — in research discovery... in expert, compassionate care... and in our strong belief in progress for people with cancer everywhere.

Website
Video
What do you #DiscoverCareBelieve? 

Immunotherapy agent benefits patients with drug-resistant multiple myeloma in first human trial

August 26, 2015

In its first clinical trial, a breakthrough antibody therapy produced at least partial remissions in a third of patients with multiple myeloma who had exhausted multiple prior treatments, investigators at Dana-Farber Cancer Institute report.

Researcher 

New Online Resource for Precision Cancer Medicine

Clinicians at Dana-Farber/Brigham and Women's Cancer Center are now armed with specialized tests to create a precise "tumor profile" for each patient's cancer. Learn about the latest thinking in precision cancer medicine from our researchers and clinicians, and explore a searchable database of clinical trials that focus on targeted therapies by disease, gene, and mutation.

Drinking coffee daily may improve survival in colon cancer patients
August 17, 2015

Regular consumption of caffeinated coffee may help prevent the return of colon cancer after treatment and improve the chances of a cure, according to a new, large study from researchers at Dana-Farber Cancer Institute.

Dana-Farber Community Cancer Care practices in Lawrence, Quincy, Stoneham, Weymouth honored for quality patient-centered care
August 17, 2015

The National Committee for Quality Assurance (NCQA) has recognized four Dana-Farber Community Cancer Care sites in Massachusetts for quality of their patient care services.

New study confirms presence of exercise-induced hormone in humans
August 13, 2015

Dana-Farber Cancer Institute scientist Bruce Spiegelman, PhD, who discovered a hormone linked to some of the positive benefits of exercise, reports he has confirmed the hormone — named irisin — is produced in humans and increases during exercise.

Religion rarely part of ICU conversation (Reuters)

September 01, 2015

Dr. Tracy Balboni wrote an editorial for a study that found doctors and other health care providers discussed religion or spirituality in less than 20 percent of family meetings in the intensive care unit.

What Doctors Want You to Know About Breast Cancer (Woman's Day)
August 28, 2015

Dr. Harold Burstein provided insight to dispel some of the myths about what causes breast cancer.

Experimental Drug for Blood Cancer Shows Promise (philly.com)
August 27, 2015

Dr. Paul Richardson led a study that found an experimental immune-boosting drug shows promise in fighting the blood cancer multiple myeloma.

Explosion Of New Cancer Treatments Presents A 'Very Exciting Time' (npr.org)
August 24, 2015

Dr. Elizabeth Buchbinder discussed former president Jimmy Carter’s announcement that he has been diagnosed with melanoma and the latest treatment options available.

Sox manager Farrell has cancer; stepping away from team (Boston Globe)
August 17, 2015

Dr. Matthew Davids commented on Boston Red Sox manager John Farrell’s announcement of being diagnosed with lymphoma.

Former president Jimmy Carter has cancer (USA Today)
August 13, 2015

Dr. Charles Fuchs commented on former president Jimmy Carter’s announcement that he has cancer.

Suicidal Ideation Higher for Cancer Survivors (MedPageToday)
August 05, 2015

Research by Dr. Christopher Recklitis reported cancer survivors showing few signs of depression are still at significant risk for suicide.

Breast Cancer Support Group-Milford

September 02, 2015

4:30 PM - 5:30 PM

20 Prospect Street, Milford, 2nd Floor Conference

Breast Cancer Support Group-Milford more

Young Adult Support Group(5)

September 02, 2015

5:30 PM - 7:00 PM

Yawkey Center, 3rd Floor, Room 306

For patients in their 20’s and 30’s who are in treatment or recently completed treatment. 

This group offers young adult patients the opportunity to share their experience in a safe, confidential setting.

The group is free and open to the public; you do not need to be a Dana-Farber patient to attend. 

 

Facilitated by Bruce MacDonald, LICSW
Registration is required. Contact Bruce at (617)632-5657 or bmacdonald1@partners.org 

Parking validated in Yawkey Garage 

more

Caring for the Caregiver-Milford

September 02, 2015

6:00 PM - 7:00 PM

20 Prospect Street, Milford, 2nd Floor Conference

This is a support group for those who have a loved one or friend with cancer.  The program will provide practical information to support you  in your role as a caregiver, as well as offer an opportunity to meet and gain support from others coping with similar issues.                                                    

Call Ann Sullivan LICSW to register 508-488-3783

Refreshments provided

more

  •  
  • Patient referral information, clinical resources and more.

  • Make an Appointment


    For adults:
    877-442-3324

    Quick access: Appointments as soon as the next day for new adult patients

    For children:
    888-733-4662


    Request Appointment Online

  • Clinical Trials

    Search current cancer clinical trials at Dana-Farber.

  • How to Help

    Yawkey Center for Cancer Care entrance 

    There are many ways to support Dana-Farber and the Jimmy Fund.

    give now button
  • Top-ranked

    • U.S. News Best Hospitals Cancer 2015-2016 logo    U.S. News Best Children's Hospitals Cancer 2015-2016 logo 

    Top-ranked cancer center in New England for adults (with Brigham and Women's Hospital) — #1 in the nation for children (with Boston Children's Hospital)

  • Dana-Farber Blog

    Insight Blog screenshot

    Insight features the latest in cancer care and research news from Dana-Farber.
    Read the blog

  • Dana-Farber eNewsletter

    Dana-Farber Spotlight 

    Stay current on the latest news by signing up for Spotlight, our email newsletter.
    View current issue
    Subscribe now